SG
HALO icon

StoneX Group’s Halozyme HALO Stock Holding History

StoneX Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Buy
5,845
+2,195
+60% +$150K 0.02% 622
2026
Q1 		$236K Hold
3,650
– – 0.01% 676
2025
Q4 		$246K Buy
3,650
+132
+4% +$8.88K 0.01% 786
2025
Q3 		$258K Buy
+3,518
New +$234K 0.01% 744
2025
Q2 		– Sell
-4,339
Closed -$277K – 947
2025
Q1 		$277K Buy
+4,339
New +$252K 0.02% 670

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

StoneX Group's HALO Position: Q2 2026 in Review

StoneX Group increased its Halozyme (HALO) stake by 60% in Q2 2026, buying an estimated $150K and bringing the position to 5,845 shares worth $444K. The position accounts for 0.02% of the portfolio, ranked #622.

StoneX Group first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • StoneX Group held 5,845 shares of Halozyme worth $444K as of Q2 2026.
  • StoneX Group bought 2,195 Halozyme shares in Q2 2026, an estimated $150K.
  • Halozyme made up 0.02% of StoneX Group's portfolio in Q2 2026, its #622 holding.
  • StoneX Group first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.